Triptans and serotonin syndrome

Cephalalgia

Volumn 28, Issue 5, 2008, Pages 573-574

  Evans, R W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELETRIPTAN; FLUOXETINE; HYPERICUM EXTRACT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRIPTAN DERIVATIVE;

COXSACKIE VIRUS B; HUMAN; LETTER; MENINGOENCEPHALITIS; MIGRAINE; RHABDOMYOLYSIS; SEROTONIN SYNDROME; VIRUS MENINGITIS;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; HYPERICUM; MIGRAINE DISORDERS; RHABDOMYOLYSIS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; TRYPTAMINES;

EID: 41849129580     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01552_1.x     Document Type: Letter

References (9)

1. Bonetto N, Santelli L, Battistin L, Cagnin A. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Cephalalgia 2007 27 : 1421 3.
2. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003 96 : 635 42.
3. Fodili F, van Bommel EF. Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection. Neth J Med 2003 61 : 177 9.
4. US Food and Drug Administration. Information for healthcare professionals. Selective serotonin reuptake inhibitors (SSRIs), selective serotonin-norepinephrine reuptake inhibitors (SNRIs), 5-hydroxytryptamine receptor agonists (triptans). 2006. [WWW document]. URL http://www.fda.gov/cder/ drug/InfoSheets/HCP/triptansHCP.htm Last accessed 5 February 2008
5. Evans RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. Med Gen Med 2007 9 : 48. [WWW document]. URL http://www.medscape.com/viewarticle/561741 Last accessed 5 February 2008
6. Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005 28 : 205 14.
7. Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J General Pract 1999 49 : 871 4.
8. Shapiro RE, Tepper SJ. The serotonin syndrome, triptans, and the potential for drug-drug interactions. Headache 2007 47 : 266 9.
9. Putnam GP, O'Quinn S, Bolden-Watson CP, Davis RL, Gutterman DL, Fox AW. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study. Cephalalgia 1999 19 : 668 75.